BSE – World’s Situation and The Danger of Outbreak of the Disease in Israel
(Following the methodology of the Scientific Steering Committee of the EU
on the Geographical Risk of BSE, 6 July 2000)
Oded Nir (Markusfeld) BVSC, MRCVS
CVO, Israel

Since BSE first appeared in England in the late eighties, the Israeli veterinary Services (IVSAH) follows the developments outside Israel routinely, and reacts accordingly.

No cases of BSE have yet been diagnosed in Israel. The risk of an outbreak of the disease in Israel depends mainly on the:

(a) probabilities that the causative agent of the disease (the prion?) entered the country through infected live cattle or contaminated cattle meat and bone meal, MBM (the “external threat”); and

(b) the infected material being recycled (rendered) and introduced into the feed chain of the local cattle (the “internal risk”).

If vCJD in human is associated with BSE in cattle, such cases could be the result of eating contaminated meat either produced in Israel or imported into the country.

The External Threat

The external threat is the outcome of the probabilities that BSE actually entered the country through live cattle or MBM and the amounts imported since the late eighties.

Import of Live Animals into Israel

Live cattle have not been imported from GB since 1974. Import from all other countries, since 1992, was allowed only from herds, which had not been fed with MBMs, and - if from countries known to be infected with BSE (e.g. France) - only from areas free of BSE. The imports since 1980 are described in the Table 1.

Table 1:
 
Year
Country
Amount
Purpose (all beef)
1980 “Europe” 90 Bull calves for breeding
1981 “Europe” 115 Bull calves for breeding
1982 No import    
1983 France 93 Bull calves for breeding
1984 France 114 Bull calves for breeding
1985 France 104 Bull calves for breeding
1986 France, Germany, Germany 130, 11, 500 Bull & female calves, heifers for breeding
1987 France, France, Germany 156, 68, 725 Bull & female calves, heifers for breeding
1988 France 67 Bull calves for breeding
1989 France 55 Bull calves for breeding
1990 France 55 Bull calves for breeding
1991 No import    
1992 France 262 Bull calves for breeding
1993 France, Germany  886, 94 Fattening, heifers for breeding
1994 Germany, France & Germany 70, 231 Fattening, bull calves for breeding
1995 France & Germany, France  68, 394, 150 Bull calves for breeding, slaughtering*
1996 France 50, 63 Heifers, bull calves for breeding
1997 France 87 Bull calves for breeding
1998 France 110, 570 Bull calves for breeding, slaughtering*
1999 France 62 Bull calves for breeding
2000 Germany 132 Bull calves for breeding
* All bull calves for slaughtering were under the age of 18 months, slaughtered within 8 days of arrival to Israel.

Import of MBM into Israel

The import of MBM of mammalian origin from the UK and from all other countries was prohibited in 1988 and 1990 respectively. The import of poultry MBM was permitted only from plants authorised by the local veterinary authorities. The purpose of the authorisation was to ensure that the MBM is produced in the plant specifically allocated for poultry MBM, and follows the specified requirements set out by the IVSAH.

The imported MBMs have been tested since 1996 against mammalian antigens to ensure that the protein does not come from mammalian sources. It came to our notice only recently that mammalian antigens are destroyed in the process of rendering that involves heat treatment above 121oC. Prions, the agents possibly responsible for BSE, are only destroyed at 133oC. The test used could not therefore have guaranteed that imported “poultry” MBMs do not contain mammalians’ proteins. Shipments from GB (the most risky source) are accompanied by MAFF’s labs’ certificates based on tests, which diagnose mammalian antigens even after heating to 140oC for 90 minutes. The import of MBM (in tons),from all animal species, in the relevant period from European countries is described in the Tables 2:

Table 2:
 
 
United Kingdom 
France
Holland
Denmark
 

Year
Poultry
By-
Product
Feather
Meal
Poultry
By-
Product
Feather
Meal
Poultry
By-
Product
Feather
Meal
Poultry
By-
Product
Feather
Meal
Fish
Meal
1986
   
40*
         
1730
1987
               
1680
1988
17
 
20*
 
597*
22
   
1092
1989
3844
29
     
343
3947*
 
489
1990
3590
1629
**40
399
**1470
1419
**1076
 
461
1991
8937
3726
173
1028
       
244
1992
7928
4482
165
409
 
91
***2594
 
223
1993
8164
6423
328
1031
 
93
1157
 
82
1994
2064
3131
598
2048
294
1015
898
21
167
1995
2002
3096
305
840
 
766
180
 
175
1996
443
1288
             
1997
3247
881
485
1593
145
1940
   
177
1998
5258
1334
541
956
 
619
   
1311
1999
6137
339
337
535
 
405
   
125
2000
1111
623
430
   
850
   
117
  
 
Belgium
Germany
Italy
Spain
 

Year
Poultry
By-
Product
Feather
Meal
Poultry
By- Product
Feather
Meal
Poultry
By- Product
Feather
Meal
Poultry
By- Product
Feather
Meal
Fish
Meal
1986
810*
     
1200*
 
1450*
790
 
1987
1150*
10
1771*
 
1000*
 
1752*
47
 
1988
802*
 
1053*
 
6737*
 
2808*
1298
 
1989
1100*
5
6374*
264
1820*
 
2929*
2410
 
1990
1220**
5
2688**
470
300**
 
1110**
689
 
1991
   
343
 
3548
98
316
191
 
1992
   
507
 
3872
304
   
75
1993
                 
1994
       
3572
55
     
1995
       
1866
       
1996
                 
1997
   
55
 
18
       
1998
   
110
           
1999
                 
2000
   
****23
           
*Poultry by-product might have included mammalian MBM before 1989.

** A total ban on all mammalian MBM was imposed in 07/1990.

*** Porcine MBM (from a plant dealing exclusively with pig material).

**** Poultry blood meal.

The external threat, if exists, could be summed up in the penetration of unknown quantities of BSE agents in into Israel, through MBM exported as “poultry MBM”, if in spite of the certification of the veterinary authorities in the exporting countries, the poultry MBMs were contaminated to various degrees with mammalian MBMs (and therefore possibly with the BSE agents). A complete fraud (selling cattle MBM as poultry one) is practically impossible because of the different contents of mammalian MBMs, poultry MBMs and feathers’ meals, which are obviously checked by the importing feed mixtures manufacturers (Table 3):

Table 3:
 
 
Ruminant meals
Poultry Meals
 
Meat
Meat & Bone
Feather 
By-Product
Crude Protein (%) 55.0 50.0 80.0 60.0
Crude Fat (%) 10.0 10.0 6.0 12.0
Crude Ash (%) 15.0 28.8 2.8 15.5
Calcium (%) 8.5 10.1 0.3 3.0
Phosphorus (%) 3.5 5.0 0.6 1.7
The risk of introduction of the disease through the imported bulls could be estimated as negligible.

The Internal Threat or the System Stability
The ability of the Israeli internal system to minimise the spread of the agent responsible for BSE, were it to enter the country, depends on preventing the recycling of infected material (rendering) into the feed chain.

Since 1996, Israel prohibits by law (and in practice) recycling of mammals. Recycling of poultry is allowed. All mammalian wastes (carcasses and organs) are buried in authorised sites, and since December 2000 are directed to one central incinerator. Cattle in Israel are not fed with mammalian MBM, in practice since the early seventies due to economical considerations, and by law since August 1996. Poultry and fishmeals are still allowed to be fed to cattle.

It is possible to estimate the system stability as good, and the internal threat as minimal.

The Actual Hazard (the Interaction of the Total Threat and Stability in Time)

The risk of an outbreak of BSE in Israel is the result of the interaction of the system stability and the external threat in the relevant period. In a stable system exposed to an external threat, the internal threat will be minimal, because without recycling the penetrating disease agent is bound to disappear with time. In an unstable system exposed to an external threat, the agent will spread through the cattle MBM. Some of the cattle, when reaching the “right” age, will turn out to be clinical cases of BSE. Others will be recycled, magnifying the amount of infected material and developing the disease into an epidemic.

The minimal period needed to diagnose the internal threat in an unstable country exposed to BSE is at least one “incubation period” of 5 years. The period could be the multiplication of few such periods and longer according to the extent of exposure to the BSE agent (the system stability, the size of the cattle population, the age dynamics of the population) and the quality of the monitoring system.

Of the four possible combinations, we estimate that the expected one in Israel is either [a stable system * none or a minimal external threat] or [a stable system * a high external threat]. The first alternative is the less hazardous, but even in the second one the system is able, with time, to remove the BSE agents. The choice between those two alternatives (the actual situation in Israel) depends in our case on the credibility of the British, French and German Veterinary Services and the efficiency of the control measures applied by the IVSAH.

It can not be over-emphasised that all mutual veterinary activities that accompany international trade, regarding BSE as well as all other diseases, are necessarily based on that credibility and certification.

The Actual Situation, the Efficiency of the Monitoring System

The efficiency of the monitoring system depends on the efficiency of the clinical system, the validity of the sample monitored, and the diagnostic methods applied.

The clinical monitoring and reporting system in the Israeli cattle industry is probably among the most efficient in the world, due to the fact that over 90% of the bovine veterinary practice in Israel is comprehensive, given under contract, and provided by a central, country-wide organisation ("Hachaklait"). Compensation for wastes and fallen stock is regulated by a state-compulsory insurance scheme, so that clinical follow up of fallen stock is guaranteed. The awareness of the system to the disease is well developed through lectures and pamphlets; the first of them described the symptoms of the disease to all the parties involved as early as 1989. The disease is notifiable in Israel since April 1992.

The present diagnostic methods allow diagnosis of the BSE agent only after death, and only when the disease is in its clinical stage or towards the end of the incubation period. The Pathology Department of the Kimron Veterinary Institute (KVI) is able to diagnose the disease since 1992 and maintains active surveillance.

In the years 1997 to 1999 for example, the KVI examined 586 brains of cows older than 36 months, all proved to be BSE negative. The Israeli bovine population in that age group is about 120,000; it is possible to calculate the probabilities of diagnosing infected cows if the disease actually exists in Israel. In a random sample, 2800 brains of cattle should have been examined annually to establish that the disease incidence in Israel is smaller than 0.1%. In Israel most of the brains of cattle showing nervous symptoms are sent to the KVI because of the compulsory obligation to examine it for rabies. 162 cows that showed nervous symptoms before their death were examined in the KVI in the period 1997 through 1999. It is possible to estimate on basis of that selected sample that the disease incidence of BSE, if exists, is smaller than 0.01%.

Import of Bovine Meat

It is believed that the prions responsible for BSE are not found in cattle younger than 30 months. No meat from Britain was allowed import since - the latest - 1986 (an official ban was applied in 1989). Import from other countries was allowed after evaluating the quality and credibility of the exporting country's State Veterinary Services by means of a detailed questionnaire with special emphasis upon BSE surveillance and the use of MBMs, and receiving a valid BSE risk analysis as demanded by the guidance of the OIE until mid December 2000. In practice we set an age limit for imported meat (36 months from South America, and 24 months from Europe).   

Updated 1 March 2001